Influence of the in situ component in 389 infiltrating ductal breast carcinomas

Breast Cancer

Volumn 20, Issue 3, 2013, Pages 213-217

  Carabias Meseguer, Pau ^a   Zapardiel, Ignacio ^b   Cusidó Gimferrer, Maite ^a   Godoy Tundidor, Sonia ^b   Tresserra Casas, Francesc ^a   Rodriguez García, Ignacio ^a   Fábregas Xauradó, Rafael ^a   Xercavins Montosa, Jordi ^c  

^a INSTITUT UNIVERSITARI DEXEUS   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Infiltrating ductal carcinoma; Intraductal carcinoma; Lymph node involvement

Indexed keywords

ADULT; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER PROGNOSIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; INTRADUCTAL CARCINOMA; LYMPH NODE; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TUMOR NECROSIS; BREAST TUMOR; COMPARATIVE STUDY; MIDDLE AGED; MORTALITY; PAGET NIPPLE DISEASE; PATHOLOGY; PROGNOSIS;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; LYMPH NODES; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; SURVIVAL RATE;

EID: 84880008527     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/s12282-011-0330-1     Document Type: Article

References (27)

1. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Eng J Med. 1985;312:146-51. (Pubitemid 15192861)
2. Dupont WD, Anderson TJ, Rogers LW. Epithelial hyperplasia. In: Diagnostic histopathology of the breast. Edinburgh: Churchill Livingstone; 1987. p. 120-56.
3. Tresserra F, Grasses PJ, Garrido M. Lesiones hiperplásicas y preinvasivas precursoras del cáncer de mama: desde la epiteliosis hasta la neoplasia ductal intraepitelial. Rev Senología Patol Mam. 2006;19:162-4.
4. Connolly JL, Boyages J, Schnitt SJ, Recht A, Silen W, Sadowsky N, et al. In situ carcinoma of the breast. Annu Rev Med. 1989;40:173-80. (Pubitemid 19145350)
5. Dundar MM, Badve S, Bilgin G, Raykar V, Jain R, Sertel O, Gurcan MN. Computerized classification of intraductal breast lesions using histopathological images. IEEE Trans Biomed Eng. 2011;58(7):1977-84.
6. Allred DC. Ductal carcinoma in situ: terminology, classification, and natural history. J Natl Cancer Inst Monogr. 2010;2010(41):134-8.
7. Buerger H, Mommers EC, Littman R, Simon R, Diallo R, Poremba C, et al. Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least 2 different lines of genetic evolution. J Pathol. 2001;194:165-70. (Pubitemid 32519965)
8. Hwang ES, DeVries S, Chew KL, Moore DH 2nd, Kerlikowske K, Thor A, et al. Patterns of chromosomal alterations in breast ductal carcinoma in situ. Clin Cancer Res. 2004;10:5160-7. (Pubitemid 39099791)
9. Irvine T, Fentiman IS. Biology and a treatment of ductal carcinoma in situ. Expert Rev Anticancer Ther. 2007;7:135-45. (Pubitemid 46277279)
10. Wiechmann L, Kuerer HM. The molecular journey from ductal carcinoma in situ to invasive breast cancer. Cancer. 2008;112(10):2130-42. (Pubitemid 351628621)
11. Porter D, Lahti-Domenici J, Keshaviah A, Bae YK, Argani P, Marks J, et al. Molecular markers in ductal carcinoma in situ of the breast. Mol Cancer Res. 2003;5:320-8.
12. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer, I: the value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19:403-10.
13. Silverstein MJ, Poller DN, Waisman JR, Colburn WJ, Barth A, Gierson ED, et al. Prognostic classification of breast ductal carcinoma in situ. Lancet. 1995;345:1154-7.
14. Tresserra F, Martínez MA. Factores pronósticos en el cáncer de mama: parte I. Factores morfológicos. Rev Senología Patol Mam. 2008;21:170-4.
15. O'Connell P, Pekkel V, Fuqua SA, Osborne CK, Clark GM, Allred DC. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. J Natl Cancer Inst. 1998;90:697-703. (Pubitemid 28222144)
16. Chuaqui RF, Zhuang Z, Emmert-Buck MR, Liotta LA, Merino MJ. Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast. Am J Pathol. 1997;150(1):297-303. (Pubitemid 27027118)
17. O'Malley FP, Pinder SE. Breast pathology. 1st ed. Philadelphia: Churchill Livingstone; 2006.
18. Malafa M, Chaudhuri B, Thomford NR, Chadhuri PK. Estrogen receptors in ductal carcinoma in situ of the breast. Am Surg. 1990;56:436-9. (Pubitemid 20227904)
19. Barnes R, Masood S. Potential value of hormone receptor assay in carcinoma in situ of breast. Am J Clin Pathol. 1990;94:533-7. (Pubitemid 20369713)
20. Chaudhuri B, Crist KA, Mucci S, Malafa M, Chaudhuri PK. Distribution of estrogen receptor in ductal carcinoma in situ of the breast. Surgery. 1993;113(2):134-7. (Pubitemid 23060520)
21. Poller DN, Galea M, Pearson D, Bell J, Gullick WJ, Elston CW, et al. Nuclear and flow cytometric characteristics associated with overexpression of the c-erbB-2 oncoprotein in breast carcinoma. Breast Cancer Res Treat. 1991;20:3-10.
22. Visscher DW, Sarkar FH, Crissman JD. Correlation of DNA ploidy with c-erbB-2 expression in preinvasive and invasive breast tumors. Anal Quant Cytol Histol. 1991;13:418-24.
23. Lodato RF, Maguire HC Jr, Greene MI, Weiner DB, LiVolsi VA. Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast. Mod Pathol. 1990;3:449-54.
24. Allred DC, Mohsin SK. Biological features of premalignant disease in the human breast. J Mammary Gland Biol Neoplasia. 2000;5:351-64. (Pubitemid 32236767)
25. Allred DC, Clark GM, Elledge R, Fuqua SA, Brown RW, Chamness GC, et al. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst. 1993;85:200-6. (Pubitemid 23046895)
26. Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell. 2004;6:17-32. (Pubitemid 38903159)
27. Hu M, Yao J, Cai L, Bachman KE, van den Brule F, Velculescu V, et al. Distinct epigenetic changes in the stromal cells of breast cancers. Nat Genet. 2005;37:899-905. (Pubitemid 41077119)